Introduction

Candida parapsilosis is a versatile yeast that inhabits various niches within the human body. Often existing as a commensal organism, it plays a complex role in the human mycobiome. While it typically maintains a balanced presence, changes in the host's health or environment can lead to its proliferation. Understanding the functional potential of C. parapsilosis across different ecosystems is key to recognizing how it transitions from a harmless resident to an opportunistic pathogen during states of dysbiosis.

Location of Microbe

Skin

In the skin ecosystem, C. parapsilosis acts as a common colonizer. It is frequently found in health care settings, where it can persist on the skin of residents in nursing homes and long-term care facilities, often alongside other Candida species.

Oral

Within the oral and respiratory tract, this yeast is identified in the sputum of individuals with chronic obstructive pulmonary disease (COPD), where it contributes to the diverse fungal community of the airways.

Gut

In the gut ecosystem, C. parapsilosis is a component of the intestinal mycobiome. Its abundance can vary significantly depending on the host's immune status and overall microbial diversity.

Behavior During Dysbiosis

Skin

During skin dysbiosis, particularly in healthcare environments, C. parapsilosis can increase in abundance. Disruption of commensal microbial communities may facilitate its colonization and subsequent transmission between patients.

Oral

In the context of airway dysbiosis, such as in AECOPD patients, C. parapsilosis is among the most prevalent species detected in sputum, where its presence is associated with varying degrees of lung inflammation.

Gut

In the gut, C. parapsilosis becomes enriched during states of immune compromise, such as in people living with HIV, or in systemic inflammatory conditions like gouty arthritis and osteoarthritis.

Disease Associations

Skin Associations

In the skin ecosystem, C. parapsilosis is associated with colonization in nursing home residents and is frequently identified in diabetic foot ulcers (DFUs), specifically within ischaemic and penetrating bone wounds, where it may contribute to complex polymicrobial biofilms.

Oral and Respiratory Associations

Within the respiratory system, C. parapsilosis is associated with Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD), where it is one of the five most prevalent species in sputum. It is also significantly enriched in patients with Squamous Cell Carcinoma (SCC) of the lung and is common in the sputum of patients with Cystic Fibrosis (CF), where it can dominate the fungal burden in cases of overt fungal bronchitis.

Gut and Systemic Associations

In the gut, C. parapsilosis is associated with several systemic and inflammatory conditions. It is enriched in the gut mycobiomes of patients with gouty arthritis and osteoarthritis (OA), potentially serving as a biomarker for these conditions. Furthermore, in people living with HIV (PWH), its enrichment is positively correlated with proinflammatory cytokines such as IL-17 and IL-22, as well as increased CD8+ T cell counts, suggesting a role in systemic innate and adaptive immune responses.

Foods Supporting Healthy Balance

Maintaining a balanced mycobiome involves supporting the overall gut ecosystem to prevent the overgrowth of opportunistic fungi. A diet rich in vegetables and dietary fibers (both soluble and insoluble) is strongly associated with a healthy fungal community. Fiber-degrading bacteria, such as those from the Faecalibacterium and Subdoligranulum genera, work in tandem with the mycobiome to maintain homeostasis. These butyrate-producing bacteria help regulate inflammatory signaling and support gut barrier integrity, which in turn prevents the opportunistic expansion of yeasts like C. parapsilosis.

Additionally, the consumption of probiotic yeasts, such as Saccharomyces cerevisiae, may help keep non-albicans Candida species in check. Research suggests that certain probiotic strains can inhibit the virulence traits of C. parapsilosis, including its ability to adhere to epithelial cells and form biofilms, thereby reducing its pathogenic potential within the gastrointestinal tract.

Actionable Insights

• Increase Fiber Intake: Consume a variety of vegetables and fiber-rich foods to support the growth of beneficial bacteria that maintain a balanced gut mycobiome.
• Incorporate Probiotics: Consider food-derived probiotic yeasts (like S. cerevisiae) which may inhibit the biofilm formation and adhesion of opportunistic fungi.
• Skin Care and Hygiene: For individuals in high-risk settings (like nursing homes) or those with diabetic ulcers, maintain rigorous skin hygiene to prevent the colonization and spread of opportunistic yeasts.
• Oral Health: Regular oral hygiene and respiratory health monitoring are important, especially for those with chronic lung conditions, to manage the diversity of the airway mycobiome.
• Monitor Immune Health: Since C. parapsilosis often expands during immune compromise, supporting general immune function through nutrition and medical guidance is essential.

Conclusion

The impact of Candida parapsilosis on human health is highly dependent on its strain and the specific niche context. In the skin, it often behaves as a commensal, though it can become a concern in healthcare settings or chronic wounds. In the oral and respiratory ecosystems, its presence is often associated with inflammatory lung diseases and specific cancer subtypes. Within the gut, it serves as an indicator of immune status and is associated with systemic inflammatory conditions. By focusing on microbial diversity and supporting the gut-skin axis through diet and probiotics, it is possible to maintain the balance of this yeast and prevent its transition toward dysbiosis.